Screener
Thermo Fisher Scientific TMO Life Sciences Solutions — Depreciation of property, plant and equipment
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Thermo Fisher Scientific in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The source filing: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 11:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000097745-26-000092
| (In millions) | Unallocated amounts | Life Sciences Solutions | Analytical Instruments | Specialty Diagnostics | Laboratory Products and Biopharma Services | Consolidated |
|---|---|---|---|---|---|---|
| Segment assets | $98,434 | $3,490 | $3,104 | $1,332 | $6,921 | $113,281 |
| Purchases of property, plant and equipment | 28 | 20 | 36 | 35 | 259 | 376 |
| Depreciation of property, plant and equipment | — | 70 | 26 | 24 | 186 | 306 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Thermo Fisher Scientific's life sciences solutions — depreciation of property, plant and equipment?
- Thermo Fisher Scientific (TMO) reported life sciences solutions — depreciation of property, plant and equipment of $70M in Q1 2026.
- How has Thermo Fisher Scientific's life sciences solutions — depreciation of property, plant and equipment changed year-over-year?
- Thermo Fisher Scientific's life sciences solutions — depreciation of property, plant and equipment increased by 18.6% year-over-year, from $59M to $70M.
- What is the long-term trend for Thermo Fisher Scientific's life sciences solutions — depreciation of property, plant and equipment?
- Over 3 years (2021 to 2025), Thermo Fisher Scientific's life sciences solutions — depreciation of property, plant and equipment has grown at a 8.4% compound annual growth rate (CAGR), from $197M to $251M.
- What does life sciences solutions — depreciation of property, plant and equipment mean?
- This metric represents the systematic allocation of the cost of tangible assets within the Life Sciences Solutions segment over their useful lives. It serves as a non-cash expense that reflects the wear and tear or obsolescence of manufacturing and laboratory equipment used in the segment's operations. Analyzing this figure helps investors assess the age of the asset base and the ongoing reinvestment needs of the business.
Ask your AI about Thermo Fisher Scientific's life sciences solutions — depreciation of property, plant and equipment.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude